Article
Cellular mechanisms of RET receptor dysfunction in multiple endocrine neoplasia 2.
Endocrine-related cancer - 1 Jan 2025
Walker Timothy J, Mulligan Lois M
Abstract excerpt
Abstract: Rearranged during transfection (RET) is a developmentally important receptor tyrosine kinase that has been identified as an oncogenic driver in a number of cancers. Activating RET point mutations gives rise to the inherited cancer syndrome multiple endocrine neoplasia type 2 (MEN2), characterized by medullary thyroid carcinoma. There are two MEN2 subtypes, MEN2A and MEN2B, that differ in tumour...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
